rheumatology and orthopaedics Flashcards
osteoporosis: summarise the pathology and radiographic features of osteoporosis
what are metabolic bone diseases
group of diseases that cause reduced bone mass and
reduced bone strength
what causes metabolic bone diseases
imbalance of various chemicals in the body
vitamins, hormones, minerals, etc
effect of metabolic bone diseases on bone
altered bone cell activity, rate of mineralisation, or
changes in bone structure
what bone mineral density T-score defines osteoporosis, and what measures this
-2.5 or lower, measured by DEXA (standard deviations different from mean peak bone mass BMD); normal microstructure but decreased bone mass
2 primary causes of osteoporosis (no external cause)
age, post-menopause (5-7 years after)
4 secondary causes of osteoporosis (external causes)
drugs, systemic disease, nutritional defects, genetic conditions
high vs low turnover osteoporosis
high turnover (formation and resorption increased, but resorption > formation) vs low turnover (both decreased, but formation < resorption)
osteoporotic bone vs normal bone
large sections of trabecular bone reabsorbed (free-floating, thinner), followed by thinning of cortical bone, causing compression fractures in long bone; identified by serum markers
define pathology
disease process that gives rise to symptoms, signs,
biochemical disturbances and changes in imaging
appearance
define radiological sign
change in imaging appearance, whether structural or functional, that may point towards a pathology
2 functions of imaging relating to bone functions
reveal structural failures such as fractures and ligamentous injuries, serve as proxy to metabolic dysfunction
5 imaging techniques
x-rays, CT, bone densitometry, MRI, radionuclide bone scans
what 3 techniques look at density
x-rays, CT, (both: less dense = darker, more dense = lighter), bone densitometry e.g. DEXA
what does MRI look at
biochemical composition (whiter areas show fat)
what do radionuclide bone scans look at
bone turnover (e.g. hotter at degenerative disease sites)